Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Amendment history:
  • Correction (January 1979)

Research Article Free access | 10.1172/JCI109244

Hypophosphatemia and Rhabdomyolysis

J. P. Knochel, C. Barcenas, J. R. Cotton, T. J. Fuller, R. Haller, and N. W. Carter

Veterans Administration Hospital, Dallas, Texas 75216

The University of Texas Health Science Center at Dallas, Southwestern Medical School, Dallas, Texas 75235

Find articles by Knochel, J. in: PubMed | Google Scholar

Veterans Administration Hospital, Dallas, Texas 75216

The University of Texas Health Science Center at Dallas, Southwestern Medical School, Dallas, Texas 75235

Find articles by Barcenas, C. in: PubMed | Google Scholar

Veterans Administration Hospital, Dallas, Texas 75216

The University of Texas Health Science Center at Dallas, Southwestern Medical School, Dallas, Texas 75235

Find articles by Cotton, J. in: PubMed | Google Scholar

Veterans Administration Hospital, Dallas, Texas 75216

The University of Texas Health Science Center at Dallas, Southwestern Medical School, Dallas, Texas 75235

Find articles by Fuller, T. in: PubMed | Google Scholar

Veterans Administration Hospital, Dallas, Texas 75216

The University of Texas Health Science Center at Dallas, Southwestern Medical School, Dallas, Texas 75235

Find articles by Haller, R. in: PubMed | Google Scholar

Veterans Administration Hospital, Dallas, Texas 75216

The University of Texas Health Science Center at Dallas, Southwestern Medical School, Dallas, Texas 75235

Find articles by Carter, N. in: PubMed | Google Scholar

Published December 1, 1978 - More info

Published in Volume 62, Issue 6 on December 1, 1978
J Clin Invest. 1978;62(6):1240–1246. https://doi.org/10.1172/JCI109244.
© 1978 The American Society for Clinical Investigation
Published December 1, 1978 - Version history
View PDF
Abstract

Clinical observations suggest that overt rhabdomyolysis may occur if severe hypophosphatemia is superimposed upon a pre-existing subclinical myopathy. To examine this possibility, a subclinical muscle cell injury was induced in 23 dogs by feeding them a phosphorus- and calorie-deficient diet until they lost 30% of their original weight. To induce acute, severe hypophosphatemia in the animals after partial starvation, 17 of the dogs were given large quantities of the same phosphorus-deficient diet in conjunction with an oral carbohydrate supplement, which together provided 140 kcal/kg per day.

After phosphorus and caloric deprivation, serum phosphorus and creatine phosphokinase (CPK) activity were normal. Total muscle phosphorus content fell from 28.0±1.3 to 26.1±2.5 mmol/dg fat-free dry solids. Sodium, chloride, and water contents rose. These changes resembled those observed in patients with subclinical alcoholic myopathy. When studied after 3 days of hyperalimentation, the animals not receiving phosphorus showed weakness, tremulousness, and in some cases, seizures. Serum phosphorus fell, the average lowest value was 0.8 mg/dl (P <0.001). CPK activity rose from 66±357 to 695±1,288 IU/liter (P <0.001). Muscle phosphorus content fell further to 21.1±7.7 mmol/dg fat-free dry solids (P <0.001). Muscle Na and Cl contents became higher (P <0.01). Sections of gracilis muscle showed frank rhabdomyolysis.

6 of the 23 phosphorus- and calorie-deprived dogs were also given 140 kal/kg per day but in addition, each received 147 mmol of elemental phosphorus. These dogs consumed their diet avidly and displayed no symptoms. They did not become hypophosphatemic, their CPK remained normal, and derangements of cellular Na, Cl, and H2O were rapidly corrected. The gracilis muscle appeared normal histologically in these animals.

These data suggest that a subclinical myopathy may set the stage for rhabdomyolysis if acute, severe hypophosphatemia is superimposed. Neither acute hypophosphatemia nor rhabdomyolysis occur if abundant phosphorus is provided during hyperalimentation.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1240
page 1240
icon of scanned page 1241
page 1241
icon of scanned page 1242
page 1242
icon of scanned page 1243
page 1243
icon of scanned page 1244
page 1244
icon of scanned page 1245
page 1245
icon of scanned page 1246
page 1246
Version history
  • Version 1 (December 1, 1978): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts